Urinary tract infections (UTIs) are one of the major healthcare
concerns causing an alarmingly high medical and financial burden in both
developing and developed countries. There is a significant rise in
multidrug-resistant (MDR) uropathogens, both in hospitalized and community
settings, which threatens safe and effective therapy of these infections.
The increased rates of resistance in UTIs requires the continuous
surveillance of uropathogens in the specific area to inform safe and
effective therapy. The present, retrospective, cross-sectional, descriptive
study was carried out using samples collected between 01/06/2019 and
31/05/2020 in Karachi, Pakistan, during which, n = 1500 urine samples were
collected. The samples were processed on Cystine Lactose Electrolyte
Deficient (CLED) agar, identification was carried out by using standard
biochemical tests and API 20E/20NE strips. Antimicrobial susceptibility
testing was performed using standard disk diffusion test protocol, as per
Clinical and Laboratory Standards Institute (CLSI) guidelines. Overall, n =
1189 urine samples (79.27%) showed significant bacterial growth. The median
age of affected patients was 56 years (range: 1-100) with n = 811 females
(68.21%), with patients between 61-80 years (n = 384; 32.29%) as the most
numerous age group. Regarding uropathogen distribution, the overwhelming
majority were Gram-negative bacteria (n = 986; 82.93%), the most common
causative agent being Escherichia coli (n = 648; 54.49%), followed by
Klebsiella spp. (n = 206; 17.33%) and Enterococcus spp. (n = 118; 9.92%).
Resistance rates were highest for the tested fluoroquinolones (>70% for
most species), trimethoprim-sulfamethoxazole, broad-spectrum penicillins,
and cephalosporins, while fosfomycin, carbapenems and colistin largely
retained their efficacy. The mitigation of UTIs and the emergence of
resistance may be impeded by taking appropriate measures for the better
management of patients; these interventions include improvements in the
treatment recommendations, provision of health education, and continuous
antimicrobial surveillance.